← Leaderboards
Annabelle Rodriguez
Johns Hopkins University
$7,737,696
Attributed
$7,947,089
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $807.9K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,947,089 · 10
By mechanism
R01$7,457,607 · 2
R21$418,787 · 1
M01$70,695 · 7
Top collaborators
- Adam J Adler2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- King-Wai Yau$28,664,002
- Dung T Le$5,608,820
- Craig A Fletcher$9,687,304
Others in their field
Top investigators on “Variant”
- Richard A Gibbs · Baylor College Of Medicine$367,607,426
- Richard K. Wilson · Washington University$295,336,569
- Stacey Gabriel · Massachusetts Institute Of Technology$169,231,712
- David Heimbrook · Leidos Biomedical Research, Inc.$125,120,179
- Heidi L Rehm · Broad Institute, Inc.$96,250,516
- Margaret A Pericak-Vance · Doheny Eye Institute$83,999,609
Research focus
VariantHigh Density Lipoprotein CholesterolCholesterolCardiovascular DiseasesCellsPlasmaAtherosclerosisGenesCardiovascular Disorder RiskHigh Density LipoproteinsProteinsParticipantSr-Bi ReceptorMediatingProtein DeficiencyGenotypeFemaleInsightBody Mass IndexLow-Density LipoproteinsInfertilityMacrophageLipidsProtein Expression
Grant awards (22)
Understanding how the interaction between Lag3 deficiency and hypercholesterolemia impact anti-tumor immunity and cardiovascular disease in a melanoma model$147,783
R21 · FY2024 · CA · contact PI
Understanding how the interaction between Lag3 deficiency and hypercholesterolemia impact anti-tumor immunity and cardiovascular disease in a melanoma model$271,004
R21 · FY2023 · CA · contact PI
Lympocyte Activation Gene-3 Deficiency Linked to Proinflammation and Atherosclerosis$732,924
R01 · FY2019 · HL · contact PI
Lympocyte Activation Gene-3 Deficiency Linked to Proinflammation and Atherosclerosis$732,924
R01 · FY2018 · HL · contact PI
Lympocyte Activation Gene-3 Deficiency Linked to Proinflammation and Atherosclerosis$732,924
R01 · FY2017 · HL · contact PI
Lympocyte Activation Gene-3 Deficiency Linked to Proinflammation and Atherosclerosis$762,674
R01 · FY2016 · HL · contact PI
The Role of Scavenger Receptor Class B Type 1 in Humans$665,947
R01 · FY2013 · HL · contact PI
The Role of Scavenger Receptor Class B Type 1 in Humans$520,312
R01 · FY2012 · HL · contact PI
The Role of Scavenger Receptor Class B Type 1 in Humans$205,426
R01 · FY2012 · HL · contact PI
The Role of Scavenger Receptor Class B Type 1 in Humans$714,588
R01 · FY2011 · HL · contact PI
The Role of Scavenger Receptor Class B Type 1 in Humans$807,900
R01 · FY2010 · HL · contact PI
Deficiency of the HDL receptor, SR-BI, in humans$387,569
R01 · FY2007 · HL · contact PI
DEFICIENCY OF THE HDL RECEPTOR, SR-BI, IN HUMANS$9,649
M01 · FY2007 · RR · contact PI
THE ROLE OF ROSIGLITAZONE IN MODULATING HDL CHOLESTEROL IN SUBJECTS WITH TYPE$308
M01 · FY2007 · RR · contact PI
THE ROLE OF THE HDL RECEPTOR, SCAVENGER RECEPTOR CLASS B TYPE I, IN HUMAN$308
M01 · FY2007 · RR · contact PI
Deficiency of the HDL receptor, SR-BI, in humans$399,144
R01 · FY2006 · HL · contact PI
DEFICIENCY OF THE HDL RECEPTOR, SR-BI, IN HUMANS$46,309
M01 · FY2006 · RR · contact PI
THE ROLE OF ROSIGLITAZONE IN MODULATING HDL CHOLESTEROL IN TYPE 2 DIABETES$11,725
M01 · FY2006 · RR · contact PI
Deficiency of the HDL receptor, SR-BI, in humans$408,750
R01 · FY2005 · HL
DEFICIENCY OF THE HDL RECEPTOR, SR-BI, IN HUMANS$1,598
M01 · FY2005 · RR
THE ROLE OF ROSIGLITAZONE IN MODULATING HDL CHOLESTEROL IN SUBJECTS WITH TYPE?$798
M01 · FY2005 · RR
Deficiency of the HDL receptor, SR-BI, in humans$386,525
R01 · FY2004 · HL